Effects of opioid antagonism on prolactin secretion and c-Fos/TH expression during lactation in rats

Endocrine

Volumn 25, Issue 2, 2004, Pages 131-136

  Zhang, Bo ^a   Hou, Yueping ^a   Voogt, James L ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

Endogenous opioid peptides (EOPs); Naloxone; Prolactin; Tuberoinfundibular dopaminergic (TIDA); endorphin

Indexed keywords

DOPAMINE; NALTREXONE; OPIATE ANTAGONIST; PROLACTIN; PROTEIN C FOS; TYROSINE 3 MONOOXYGENASE; NALOXONE; NARCOTIC ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARCUATE NUCLEUS; ARTICLE; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; DRUG EFFECT; FEMALE; HYPOTHALAMUS; IMMUNOCYTOCHEMISTRY; LACTATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; TRANSCRIPTION INITIATION; TUBEROHYPOPHYSEAL TRACT; ADENOHYPOPHYSIS; ANIMAL; BIOSYNTHESIS; BLOOD; ENZYMOLOGY; MALE; METABOLISM; PHYSIOLOGY; PREGNANCY; SECRETION; SPRAGUE DAWLEY RAT; SUCKLING;

ANIMALS; ANIMALS, SUCKLING; ARCUATE NUCLEUS; FEMALE; LACTATION; MALE; NALOXONE; NARCOTIC ANTAGONISTS; NEURONS; PITUITARY GLAND, ANTERIOR; PREGNANCY; PROLACTIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; TYROSINE 3-MONOOXYGENASE;

EID: 21244476822     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1385/ENDO:25:2:131     Document Type: Article

References (27)

1. Grattan, D. R., Pi, X. J., Andrews, Z. B., et al. (2001). Horm. Behav. 40, 115-124.
2. Ben-Jonathan, N. (1985). Endocrine Rev 6, 564-589.
3. Ben-Jonathan, N. and Hnasko, R. (2001). Endocrine Rev. 22, 724-763.
4. Bjorklund, A., Moore R. Y., Nobin, A., and Stenevi, U. (1973). Brain Res. 51, 171-191.
5. Rivier, C., Vale, W., Ling, N., Brown, M., and Guillemin, R. (1997). Endocrinology 100, 138-141.
6. Ferland, L., Kledzik, G. S., Cusan, L., and Labrie, F. (1978). Mol. Cell Endocrinology 12, 267-272.
7. Ieiri, T., Chen, H. T., Campbell, G. A., and Meites, J. (1980). Endocrinology 106, 1568-1570.
8. Mansour, A., Fox, C. A., Akil, H., and Watson, S. J. (1995). Trends Neurosci. 18, 22-29.
9. Minami, M. and Satoh, M. (1995). Neurosci. Res. 23, 121-145.
10. Everitt, B. J., Meister, B., Hokfelt, T., et al. (1986). Brain Res. 396, 97-155.
11. Callahan, P., Baumann, M. H., and Rabii, J. (1996). J. Neuroendocrinology 8, 771-776.
12. Mezey, E., Kiss, J. Z., Mueller, G. P., Eskay, R., O'Donobue, T. L., and Palkovits, M. (1985). Brain Res. 328, 341-347.
13. Moore, K. E. and Lookingland, K. J. (1995). In: Psychopharmacology: the fifth generation of progress. Bloom, F. E. and Kupfer, D. J. (eds.). Raven Press: New York.
14. Horvath, T. L., Naftolin, F., and Leranth, C. (1992). Endocrinology 131, 1547-1555.
15. Morel, G. and Pelletier, G. (1986). Peptides 7, 1197-1199.
16. Sagrillo, C. A. and Voogt, J. C. (1991). Endocrinology 129, 925-930.
17. Hou, Y. and Voogt, J. C. (1999). Endocrine 10, 145-152.
18. Erskine, M. S. (1995). Endocrine Rev. 16, 508-528.
19. Neill, J. D. and Nagy, G. M. (1994). In: The physiology of reproduction. 2nd ed. Knobil, E. and Neill, J. D. (eds.). Raven Press: New York.
20. Brown, B., Deffmar, P. W., Dobson, P. R., Lynn, A. G., Metcalf, G., and Morgan, B. A. (1978). J. Pharm. Pharmacol. 30, 644-645.
21. Selmanoff, M. and Gregerson, K. A. (1986). Neuroendocrinology 42, 255-259.
22. Arbogast, L. A. and Voogt, J. L. (1998). Endocrinology 139, 2857-2862.
23. Wang, H. J., Hoffman, G. E., and Smith, M. S. (1993). Endocrinology 133, 1657-1663.
24. Pape, J. R., Ciofi, P., and Tramu, G. (1996). J. Neuroendocrinology 8, 375-386.
25. Van Loon, G. R., Ho, D., and Kim, C. (1980). Endocrinology 106, 76-80.
26. Gudelsky, G. A. and Porter, J. C. (1979). Life Sci. 25, 1697-1702.
27. Arita, J. and Kimura, F. (1988). Endocrinology 123, 694-699.